Sun Pharma is all set to enter the lucrative oral contraceptive market in the US, but the going won’t be easy with the entrenched players like Teva and Watson dominating the market. CNBC-TV18’s Archana Shukla reports Sun will even have to take on its Indian peers like Glenmark and Lupin, who have an early mover advantage.
first published: Oct 28, 2011 09:54 pm
A collection of the most-viewed Moneycontrol videos.
LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook
Nifty’s Move Hinges On RBI Rate Decision; HUL, ITC Hotels In Focus| Opening Bell Live
Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
Live: RBI Policy Expectations| Rupee Slide, Strong GDP & Soft Inflation – Will MPC Cut Or Pause?
